• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类肝脏单核 RNA 测序提示 BMPR2、GDF15、精氨酸和雌激素与门脉性肺动脉高压有关。

Human liver single nuclear RNA sequencing implicates BMPR2, GDF15, arginine, and estrogen in portopulmonary hypertension.

机构信息

Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Department of Medicine, Perelman School at the University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Commun Biol. 2023 Aug 9;6(1):826. doi: 10.1038/s42003-023-05193-3.

DOI:10.1038/s42003-023-05193-3
PMID:37558836
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10412637/
Abstract

Portopulmonary hypertension (PoPH) is a type of pulmonary vascular disease due to portal hypertension that exhibits high morbidity and mortality. The mechanisms driving disease are unknown, and transcriptional characteristics unique to the PoPH liver remain unexplored. Here, we apply single nuclear RNA sequencing to compare cirrhotic livers from patients with and without PoPH. We identify characteristics unique to PoPH in cells surrounding the central hepatic vein, including increased growth differentiation factor signaling, enrichment of the arginine biosynthesis pathway, and differential expression of the bone morphogenic protein type II receptor and estrogen receptor type I genes. These results provide insight into the transcriptomic characteristics of the PoPH liver and mechanisms by which PoPH cellular dysfunction might contribute to pulmonary vascular remodeling.

摘要

肝肺高压(PoPH)是一种由门静脉高压引起的肺血管疾病,其发病率和死亡率都很高。导致这种疾病的机制尚不清楚,而 PoPH 肝脏特有的转录特征仍未被探索。在这里,我们应用单细胞核 RNA 测序来比较患有和不患有 PoPH 的患者的肝硬化肝脏。我们在围绕中央肝静脉的细胞中发现了 PoPH 特有的特征,包括生长分化因子信号的增加、精氨酸生物合成途径的富集,以及骨形态发生蛋白 II 型受体和雌激素受体 I 基因的差异表达。这些结果为 PoPH 肝脏的转录组特征以及 PoPH 细胞功能障碍可能导致肺血管重塑的机制提供了深入了解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54c2/10412637/a7fb2c250485/42003_2023_5193_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54c2/10412637/27a388b33b42/42003_2023_5193_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54c2/10412637/59ae50154e9d/42003_2023_5193_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54c2/10412637/a7fb2c250485/42003_2023_5193_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54c2/10412637/27a388b33b42/42003_2023_5193_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54c2/10412637/59ae50154e9d/42003_2023_5193_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54c2/10412637/a7fb2c250485/42003_2023_5193_Fig3_HTML.jpg

相似文献

1
Human liver single nuclear RNA sequencing implicates BMPR2, GDF15, arginine, and estrogen in portopulmonary hypertension.人类肝脏单核 RNA 测序提示 BMPR2、GDF15、精氨酸和雌激素与门脉性肺动脉高压有关。
Commun Biol. 2023 Aug 9;6(1):826. doi: 10.1038/s42003-023-05193-3.
2
Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2).雌激素信号与门肺高压:肝脏疾病相关肺血管病变研究(PVCLD2)。
Hepatology. 2021 Feb;73(2):726-737. doi: 10.1002/hep.31314. Epub 2020 Sep 29.
3
Comparison of Post-Liver Transplantation Outcomes in Portopulmonary Hypertension and Pulmonary Venous Hypertension: A Single-Center Experience.肝移植术后门脉性肺动脉高压与肺静脉高压的预后比较:单中心经验
Transplant Proc. 2017 Mar;49(2):338-343. doi: 10.1016/j.transproceed.2016.12.006.
4
Portopulmonary Hypertension: Management and Liver Transplantation Evaluation.门脉高压性肺高血压:管理与肝移植评估。
Chest. 2023 Jul;164(1):206-214. doi: 10.1016/j.chest.2023.01.009. Epub 2023 Jan 14.
5
Portopulmonary hypertension.门肺高压
Scand J Gastroenterol. 2016 Jul;51(7):795-806. doi: 10.3109/00365521.2016.1157895. Epub 2016 Mar 22.
6
Evolving dilemmas and management of portopulmonary hypertension.进展性门静脉高压的困境与管理
Semin Liver Dis. 2006 Aug;26(3):265-72. doi: 10.1055/s-2006-947294.
7
Struggling Between Liver Transplantation and Portopulmonary Hypertension.肝移植与门肺高压之间的抉择
Heart Fail Clin. 2023 Jan;19(1):55-65. doi: 10.1016/j.hfc.2022.08.017.
8
What's new in the treatment of portopulmonary hypertension?门肺高压治疗方面有哪些新进展?
Expert Rev Gastroenterol Hepatol. 2015 Jul;9(7):983-92. doi: 10.1586/17474124.2015.1035647. Epub 2015 Apr 16.
9
Portopulmonary hypertension.肝肺高压。
Semin Respir Crit Care Med. 2012 Feb;33(1):17-25. doi: 10.1055/s-0032-1301731. Epub 2012 Mar 23.
10
Pulmonary vascular abnormalities in cirrhosis.肝硬化中的肺血管异常
Best Pract Res Clin Gastroenterol. 2007;21(1):141-59. doi: 10.1016/j.bpg.2006.07.011.

引用本文的文献

1
Liver bypass in the development of pathogen-associated pulmonary vascular disease: contribution of mesocaval and portosystemic shunts.肝旁路在病原体相关肺血管疾病发展中的作用:中腔静脉分流和门体分流的影响
Am J Physiol Gastrointest Liver Physiol. 2025 Jun 1;328(6):G791-G800. doi: 10.1152/ajpgi.00409.2024. Epub 2025 May 5.
2
Aberrant long-chain fatty acid metabolism associated with evolving systemic sclerosis-associated pulmonary arterial hypertension.与进行性系统性硬化症相关肺动脉高压相关的异常长链脂肪酸代谢。
Am J Physiol Lung Cell Mol Physiol. 2024 Jul 1;327(1):L54-L64. doi: 10.1152/ajplung.00057.2024. Epub 2024 Apr 23.

本文引用的文献

1
Proline and glucose metabolic reprogramming supports vascular endothelial and medial biomass in pulmonary arterial hypertension.脯氨酸和葡萄糖代谢重编程支持肺动脉高压中的血管内皮和中膜生物量。
JCI Insight. 2023 Feb 22;8(4):e163932. doi: 10.1172/jci.insight.163932.
2
Immunohistochemical profile of the pulmonary vasculature in subjects with cirrhosis and histopathologic evidence of pulmonary vascular disease: An autopsy study.肝硬化患者肺血管免疫组织化学特征及肺血管疾病的组织病理学证据:一项尸检研究。
Respir Med. 2022 Oct;202:106969. doi: 10.1016/j.rmed.2022.106969. Epub 2022 Aug 29.
3
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
4
Single-Cell, Single-Nucleus, and Spatial RNA Sequencing of the Human Liver Identifies Cholangiocyte and Mesenchymal Heterogeneity.单细胞、单细胞核和空间 RNA 测序鉴定人类肝脏中的胆管细胞和间充质异质性。
Hepatol Commun. 2022 Apr;6(4):821-840. doi: 10.1002/hep4.1854. Epub 2021 Nov 18.
5
Liver Zonation - Revisiting Old Questions With New Technologies.肝小叶分区——用新技术重新审视老问题
Front Physiol. 2021 Sep 9;12:732929. doi: 10.3389/fphys.2021.732929. eCollection 2021.
6
Single-cell transcriptomic profile of human pulmonary artery endothelial cells in health and pulmonary arterial hypertension.人肺动脉内皮细胞在健康和肺动脉高压状态下的单细胞转录组图谱。
Sci Rep. 2021 Jul 19;11(1):14714. doi: 10.1038/s41598-021-94163-y.
7
ADAM10 and ADAM17 regulate EGFR, c-Met and TNF RI signalling in liver regeneration and fibrosis.ADAM10 和 ADAM17 调节肝再生和纤维化过程中 EGFR、c-Met 和 TNF RI 信号通路。
Sci Rep. 2021 Jun 1;11(1):11414. doi: 10.1038/s41598-021-90716-3.
8
Integrated Single-Cell Atlas of Endothelial Cells of the Human Lung.人类肺部血管内皮细胞的综合单细胞图谱
Circulation. 2021 Jul 27;144(4):286-302. doi: 10.1161/CIRCULATIONAHA.120.052318. Epub 2021 May 25.
9
Sotatercept for the Treatment of Pulmonary Arterial Hypertension.索他拉特塞治疗肺动脉高压。
N Engl J Med. 2021 Apr 1;384(13):1204-1215. doi: 10.1056/NEJMoa2024277.
10
Inference and analysis of cell-cell communication using CellChat.使用 CellChat 进行细胞间通讯的推断和分析。
Nat Commun. 2021 Feb 17;12(1):1088. doi: 10.1038/s41467-021-21246-9.